SOX9 and neoplasm: The lower tumor-forming ability of SOX9− cells was confirmed in the serial transplantation of 1.0 × 104 cells (87.5% in SOX9+ cells and 12.5% in SOX9− cells) (Fig. 2B, Supplemental Table 1).